Medium from mesangial cells incubated with aggregated IgA1 from IgA nephropathy patients reduces podocyte adhesion through activation of the renin angiotensin system

Swiss Medical Weekly

Volumn 141, Issue DECEMBER, 2011, Pages

  Wang, Cheng ^a   Liu, Xun ^a   Tang, Ying ^a   Peng, Hui ^a   Ye, ZengChun ^a   Zhang, Jun ^a   Tang, Hua ^a   Lou, Tanqi ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Adhesive; IgA nephropathy; IgA1; Medium; Mesangial cell; Podocyte

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSINOGEN; BETA N ACETYLHEXOSAMINIDASE; CHYMOSTATIN; ENALAPRILAT; MESSENGER RNA; RENIN; IMMUNOGLOBULIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ADHESION; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IN VITRO STUDY; INCUBATION TIME; MESANGIUM CELL; MOUSE; NONHUMAN; PODOCYTE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; WESTERN BLOTTING; ANIMAL; CULTURE TECHNIQUE; DRUG EFFECT; IMMUNOLOGY; MESANGIUM; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; BLOTTING, WESTERN; CELL ADHESION; CELL CULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; GLOMERULAR MESANGIUM; GLOMERULONEPHRITIS, IGA; HUMANS; IMMUNOGLOBULIN A; MICE; PODOCYTES; REAL-TIME POLYMERASE CHAIN REACTION; RENIN-ANGIOTENSIN SYSTEM;

EID: 84855290492     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: 10.4414/smw.2011.13304     Document Type: Article

References (23)

1. Li Ls, Liu Zh. Epidemiologic data of renal diseases from a single unit in China: analysis based on 13,519 renal biopsies. Kidney Int. 2004;66:920-3.
2. Nartia I, Gejyo F. Pathogenetic significance of aberrant glycosylation of IgA1 in IgA nephropathy. Clin Exp Nephrol. 2008;12:332-8.
3. van der Boog PJ, van Kooten C, de Fijter JW, de Fijter JW, Daha MR. Role of macromolecular IgA in IgA nephropathy. Kidney Int. 2005;67:813-21. (Pubitemid 41623306)
4. Ding Jx, Xu Lx, Lv Jc, Zhao Mh, Zhang H, Wang Hy. Aberrant sialylation of serum IgA1 was associated with prognosis of patients with IgA nephropathy. Clin Immunol. 2007;125:268-74. (Pubitemid 350116717)
5. Peng Ai, Gu Y, Xiao T, Zhu Ky, Zhang M, Yang Hc, et al. Clinicopathological characteristics of IgA nephropathy with urinary podocyte excretion. Chin J Nephrol. 2007;23:283-5.
6. Shanklang SJ. The podocyte's response to injury: role in proteinuria and glomerulosclerosis. Kidney Int. 2006;69:2131-47.
7. Arant T. Petermann, Ron Krofft, Mary Blonski, et al. Podocytes that detach in experimental membranous nephropathy are viable. Kidney Int. 2003,64:1222-31.
8. Mundel P, Shankland SJ. Podocyte biology and response to injury. J Am Soc Nephrol. 2002;13:3005-15. (Pubitemid 35386921)
9. Steanie U. Vogelmann, W. James Nelson, Bryan D. Myers, et al. Urinary excretion of viable podocytes in health and renal disease. Am J Physiol Renal Physiol. 2003,285:F40-48.
10. Ye Z, Wang C, Tang Y, et al. Serum IgA1 from patients with IgA nephropathy up-regulates integrin-linked kinase synthesis and inhibits adhesive capacity in podocytes through indirect pathways. Clin Invest Med. 2009;32:E20-7.
11. Wang C, Liu X, Ye Z,Zhang J, Tang H, Chen Z, Zhang H, Lou T. Mesangial medium with IgA1 from IgA nephropathy inhibit nephrin expression in podocytes Eur J Clin Invest. 2009;39:561-7.
12. Landegren U. Measurement of cell numbers by means of the endogenous enzyme hexosaminidase. Applications to detection of lymphokines and cell surface antigens. J Immunol Methods. 1984;67:379-88. (Pubitemid 14163018)
13. Cushman DW, Cheung HS. Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung. Biochem Pharmacol. 1971;20:1637-48.
14. Jennings DL, Kalus JS, Coleman CL, et al. Combination therapy with an ACE inhibitor and an angiotensin receptor blocker for diabetic nephropathy: a meta-analysis. Diabet Med. 2007;24:486-93. (Pubitemid 46669317)
15. Max CL, Lang D, Bohm J, et al. Functional expression of the renin-angiotensin system in human podocytes. Am J Physiol Renal Physiol. 2006;290:F710-F719. (Pubitemid 43724974)
16. Yadav A, Vallbu S, Arora S, et al. ANG II promotes autophagy in podocytes. Am J Physiol Cell Physiol. 2010;299:C488-96.
17. Hsu HH, Hoffmann S, Endlich N, et al. Mechanisms of angiotensin II signaling on cytoskeleton of podocytes. 2008;86:1379-94.
18. Sungmi P, Benjamin JB, Hiroyuki K, et al. Major role for ACE-independent intrarenal ANG II formation in type II diabetes. Am J Physiol Renal Physiol. 2010;298:F37-48
19. Koichi S, Gi DH, Naoko M, et al. Angiotensin II Type 1 and Type 2 Receptors Play Opposite Roles in Regulating the Barrier Function of Kidney Glomerular Capillary Wall. Am J Pathol. 2007;170:1841-53. (Pubitemid 47339259)
20. Wang Ch, Peng H, Tang H, et al. Serum IgA1 from IgA nephropathy induces apoptosis in podocytes through direct and indirect pathway. Clin Invest Med. 2007;30:E240-9. (Pubitemid 350248524)
21. Wang Y, Zhao MH, Zhang YK, et al. Binding capacity and pathophysiological effects of IgA1 from patients with IgA nephropathy on human glomerular mesangial cells. Clin Exp Immunol. 2004;136:168-75. (Pubitemid 38437779)
22. Wang Y, Zhao MH, Zhang Y, et al. Serum IgA(1) from patients with IgA nephropathy induces phosphorylation of extracellular signal-regulated kinase and proliferation of human mesangial cells. Zhonghua Yi Xue Za Zhi. 2002;82:1406-9.
23. Cecile D, Marc OB, Anthea H, et al. Mechanical forces and TGFβ1 reduce podocyte adhesion through α3β1 integrin downregulation. Nephrol Dial Transplant. 2009;24:2645-55.